Your browser doesn't support javascript.
loading
The involvement of epithelial-to-mesenchymal transition in doxorubicin resistance: Possible molecular targets.
Mirzaei, Sepideh; Abadi, Asal Jalal; Gholami, Mohammad Hossein; Hashemi, Farid; Zabolian, Amirhossein; Hushmandi, Kiavash; Zarrabi, Ali; Entezari, Maliheh; Aref, Amir Reza; Khan, Haroon; Ashrafizadeh, Milad; Samarghandian, Saeed.
Afiliação
  • Mirzaei S; Department of Biology, Faculty of Science, Islamic Azad University, Science and Research Branch, Tehran, Iran.
  • Abadi AJ; Department of Genetics, Faculty of Advanced Science and Technology, Tehran Medical Sciences, Islamic Azad University, Tehran, Iran.
  • Gholami MH; Faculty of Veterinary Medicine, Kazerun Branch, Islamic Azad University, Kazerun, Iran.
  • Hashemi F; Department of Comparative Biosciences, Faculty of Veterinary Medicine, University of Tehran, Tehran, Iran.
  • Zabolian A; Young Researchers and Elite Club, Tehran Medical Sciences, Islamic Azad University, Tehran, Iran.
  • Hushmandi K; Department of Food Hygiene and Quality Control, Division of Epidemiology, Faculty of Veterinary Medicine, University of Tehran, Tehran, Iran.
  • Zarrabi A; Sabanci University Nanotechnology Research and Application Center (SUNUM), Tuzla, 34956, Istanbul, Turkey.
  • Entezari M; Department of Genetics, Faculty of Advanced Science and Technology, Tehran Medical Sciences, Islamic Azad University, Tehran, Iran; Farhikhtegan Medical Convergence Sciences Research Center, Farhikhtegan Hospital Tehran Medical Sciences, Islamic Azad University, Tehran, Iran.
  • Aref AR; Belfer Center for Applied Cancer Science, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA; Translational Sciences, Xsphera Biosciences Inc. 6 Tide Street, Boston, MA, 02210, USA.
  • Khan H; Department of Pharmacy, Abdul Wali Khan University, Mardan, 23200, Pakistan. Electronic address: haroonkhan@awkum.edu.pk.
  • Ashrafizadeh M; Sabanci University Nanotechnology Research and Application Center (SUNUM), Tuzla, 34956, Istanbul, Turkey; Faculty of Engineering and Natural Sciences, Sabanci University, Orta Mahalle, Üniversite Caddesi No. 27, Orhanli, Tuzla, 34956, Istanbul, Turkey. Electronic address: milad.ashrafizadeh@sabanci
  • Samarghandian S; Noncommunicable Diseases Research Center, Neyshabur University of Medical Sciences, Neyshabur, Iran. Electronic address: samarghandians1@nums.ac.ir.
Eur J Pharmacol ; 908: 174344, 2021 Oct 05.
Article em En | MEDLINE | ID: mdl-34270987
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Doxorrubicina / Transição Epitelial-Mesenquimal Tipo de estudo: Prognostic_studies Limite: Humans Idioma: En Revista: Eur J Pharmacol Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Irã
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Doxorrubicina / Transição Epitelial-Mesenquimal Tipo de estudo: Prognostic_studies Limite: Humans Idioma: En Revista: Eur J Pharmacol Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Irã